Skip to content

Ibrutinib

Ibrutinib (Imbruvica) is a kinase inhibitor used to treat mantle cell lymphoma, chronic lymphocytic leukaemia and Waldenström’s macroglobulinaemia. The catalogue contains one formulation: Ibrutinib Capsules.

Ibrutinib Capsules

Mantle Cell Lymphoma

140mg

Ibrutinib capsules for mantle cell lymphoma and chronic lymphocytic leukaemia. A targeted cancer medicine that blocks a specific protein driving the cancer.

From$23.83/ capsuleView

Key points

  • Ibrutinib is a kinase inhibitor that targets Bruton’s tyrosine kinase (BTK) to slow cancer cell growth.
  • The single listed product is a capsule, a solid oral form taken by mouth.
  • Imbruvica is the originator brand for ibrutinib in this catalogue.

What Ibrutinib is used for

Ibrutinib is used to treat mantle cell lymphoma and chronic lymphocytic leukaemia, two types of blood cancer, as well as Waldenström’s macroglobulinaemia, a rare blood disorder. The medicine known as ibrutinib is listed for these three conditions in the catalogue.

Further reading